This brand name is authorized in New Zealand.
The drug DENCORUB DUAL ACTION contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
213N3S8275 - CAMPHOR, (-)-
|
2
|
UNII
2R04ONI662 - EUCALYPTUS OIL
|
|
When the vapour is inhaled eucalyptus oil acts to ventilate the bronchial passages and relieve bronchitis and associated conditions. It is also a rubefacient. |
|
3
|
UNII
L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
|
4
|
UNII
O414PZ4LPZ - SALICYLIC ACID
|
|
Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. |
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NZ | Medicines and Medical Devices Safety Authority | 14192 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.